Immunic | VTL - Operating Profit


Immunic reported $-23.33M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
BioMarin Pharmaceutical USD 105.6M 24.04M Jun/2026
Cipla INR 8.88B 2.74B Jun/2026
Clal Biotechnology ILS -1.74M 7.46M Dec/2022
Compugen USD -9.02M 65.06M Mar/2026
CSL USD 2.64B 1.97B Dec/2025
Enanta Pharmaceuticals USD -23.54M 98.15M Dec/2024
Grifols EUR 320.55M 91.01M Dec/2025
Immunic USD -23.33M 2.67M Dec/2025
Insmed USD -101.31M 98.97M Jun/2026
Omeros USD -35.41M 23.75M Sep/2024
OraSure Technologies USD -13.59M 2.13M Dec/2025
Quidel USD -15.3M 16.5M Jun/2026
Ultragenyx Pharmaceutical USD -75M 141M Jun/2026
United Therapeutics USD 330.8M 5M Jun/2026